The Nuffield Council on Bioethics invited Notre Dame Associate Professor of Law Carter Snead to speak at its “Forward Look” seminar. The seminar convenes experts in ethics, law, biology, and medicine to identify emerging issues of importance in the field of bioethics. Prof. Snead will discuss neuroimaging and neuroethics. “Forward Look” took place April 26-27, 2010, in London.
Prof. Snead’s principal area of research is public bioethics – the governance of science, medicine, and biotechnology in the name of ethical goods. His scholarly works have explored issues relating to neuroethics, enhancement, stem cell research, abortion, and end-of-life decision-making.
In addition to his scholarship and teaching, Prof. Snead has provided advice on the legal and public policy dimensions of bioethical questions to officials in all three branches of the U.S. government, and in several intergovernmental fora. Prior to joining the law faculty at Notre Dame, Professor Snead served as General Counsel to The President’s Council on Bioethics (Chaired by Dr. Leon R. Kass), where he was the primary drafter of the 2004 report, “Reproduction and Responsibility: The Regulation of New Biotechnologies.” In 2006, he testified in the U.S. House of Representatives on regulatory questions concerning RU-486 (the abortion pill).
From 2004 to 2005, Professor Snead led the U.S. government delegation and served as its chief negotiator for the Universal Declaration on Bioethics and Human Rights (adopted in October 2005). He served (along with Dr. Edmund Pellegrino) as U.S. government’s Permanent Observer to the Council of Europe’s Steering Committee on Bioethics (CDBI), where he assisted in its efforts to elaborate international instruments and standards for the ethical governance of science and medicine. In conjunction with the American Association for the Advancement of Science (AAAS), he regularly lectures to state and federal judges on the uses of neuroimaging in the courtroom.
In 2008, Prof. Snead was appointed by the Director-General of UNESCO to a four-year term on the International Bioethics Committee (IBC), a 36-member body of independent experts that advises member states on bioethics, law, and public policy. The IBC is the only bioethics commission in the world with a global mandate.
The Nuffield Council on Bioethics has achieved an international reputation for addressing public concerns, and providing independent advice to assist policy makers and stimulate debate in bioethics.